United States Pharmaceuticals

Arvinas Inc (ARVN)

Track

Track

Arvinas Inc. experienced significant insider selling over the past ninety days, totaling over one million dollars. Key executives, including the former medical officer and current financial leadership, offloaded shares through multiple transactions. These divestments occurred alongside a positive earnings report, while the stock price maintains a moderate recovery trend within its annual range.
Ticker: ARVN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Arvinas Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.8
NOAH C BERKOWITZ Former Officer Officer
Transaction date
Proposed sale
Price
79.59
Quantity 45,626
Value US$1,756,085
3.8
NOAH C BERKOWITZ Former Officer Officer
Transaction date
Proposed sale
Price
338.50
Quantity 58,488
Value US$78,796
3.8
NOAH C BERKOWITZ Officer Officer
Transaction date
Proposed sale
Price
221.79
Quantity 85,225
Value US$2,593,446
3.8
NOAH C BERKOWITZ Former Affiliate
Transaction date
Proposed sale
Price
8.40
Quantity 24,000
Value US$201,528
3.7
Saik Andrew Chief Financial Officer Officer
Transaction date
Sale
Price
8.16
Quantity 5,696 -2.9%
Value US$46,474
3.7
Andrew Saik Officer Officer
Transaction date
Proposed sale
Price
8.14
Quantity 5,846
Value US$47,586
3.9
Cacace Angela M Chief Scientific Officer Officer
Transaction date
Sale
Price
7.60
Quantity 2,576 -1.4%
Value US$19,565
3.9
Angela Cacace Officer Officer
Transaction date
Proposed sale
Price
7.42
Quantity 2,642
Value US$19,604
3.6
Teel Randy President and CEO Executive Director
Transaction date
Sale
Price
9.04
Quantity 2,209 -0.8%
Value US$19,962
3.6
Randy Teel Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.10
Quantity 2,197
Value US$19,993
4.0
Loomis David K VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
9.94
Quantity 1,919 -4.6%
Value US$19,070
3.7
Saik Andrew Chief Financial Officer Officer
Transaction date
Sale
Price
9.94
Quantity 11,139 -5.5%
Value US$110,693
3.9
Cacace Angela M Chief Scientific Officer Officer
Transaction date
Sale
Price
9.94
Quantity 9,657 -5.0%
Value US$95,965
3.8
Berkowitz Noah Chief Medical Officer Officer
Transaction date
Sale
Price
9.94
Quantity 11,108 -5.5%
Value US$110,385
3.6
Teel Randy President and CEO Executive Director
Transaction date
Sale
Price
9.94
Quantity 9,657 -3.3%
Value US$95,965
3.7
Andrew Saik Officer Officer
Transaction date
Proposed sale
Price
10.11
Quantity 11,343
Value US$114,678
3.9
Angela Cacace Officer Officer
Transaction date
Proposed sale
Price
10.11
Quantity 9,834
Value US$99,422
3.8
Noah Berkowitz Officer Officer
Transaction date
Proposed sale
Price
10.11
Quantity 11,312
Value US$114,364
3.6
Randy Teel Officer; Director Executive Director
Transaction date
Proposed sale
Price
10.11
Quantity 9,834
Value US$99,422
3.8
Berkowitz Noah Chief Medical Officer Officer
Transaction date
Sale
Price
11.10
Quantity 6,435 -3.1%
Value US$71,431
3.8
Noah Berkowitz Officer Officer
Transaction date
Proposed sale
Price
12.01
Quantity 6,022
Value US$72,324
3.3
Morrison Briggs Non-Executive Director
Transaction date
Purchase
Price
13.40
Quantity 20,000 +26.3%
Value US$268,070
4.2
Houston John G Non-Executive Director
Transaction date
Sale
Price
13.14
Quantity 11,787 -1.0%
Value US$154,881
4.2
Houston John G Non-Executive Director
Transaction date
Sale
Price
13.24
Quantity 18,822 -1.6%
Value US$249,203
4.2
Houston John G Non-Executive Director
Transaction date
Sale
Price
13.24
Quantity 4,688 -0.4%
Value US$62,069
4.2
John G. Houston former President and CEO; Director Non-Executive Director
Transaction date
Proposed sale
Price
13.21
Quantity 35,297
Value US$466,184
4.0
Loomis David K Chief Accounting Officer Officer
Transaction date
Sale
Price
12.16
Quantity 1,108 -3.6%
Value US$13,473
3.9
Cacace Angela M Chief Scientific Officer Officer
Transaction date
Sale
Price
12.16
Quantity 2,571 -1.7%
Value US$31,263
3.9
Cacace Angela M Chief Scientific Officer Officer
Transaction date
Sale
Price
12.16
Quantity 1,038 -0.7%
Value US$12,622
3.6
Teel Randy President and CEO Executive Director
Transaction date
Sale
Price
12.16
Quantity 3,748 -2.4%
Value US$45,576
3.6
Teel Randy President and CEO Executive Director
Transaction date
Sale
Price
12.16
Quantity 1,038 -0.7%
Value US$12,622
3.9
Angela Cacace Officer Officer
Transaction date
Proposed sale
Price
12.16
Quantity 3,609
Value US$43,897
3.6
Randy Teel Officer; Director Executive Director
Transaction date
Proposed sale
Price
12.16
Quantity 4,786
Value US$58,213
3.6
Teel Randy President and CEO Executive Director
Transaction date
Sale
Price
11.89
Quantity 4,403 -2.8%
Value US$52,352
3.7
Saik Andrew Chief Financial Officer Officer
Transaction date
Sale
Price
11.89
Quantity 5,134 -3.1%
Value US$61,043
3.9
Cacace Angela M Chief Scientific Officer Officer
Transaction date
Planned sale
Price
11.89
Quantity 4,592 -2.9%
Value US$54,599
3.8
Berkowitz Noah Chief Medical Officer Officer
Transaction date
Sale
Price
11.89
Quantity 5,685 -3.4%
Value US$67,595
4.0
Loomis David K Chief Accounting Officer Officer
Transaction date
Planned sale
Price
11.89
Quantity 1,016 -3.2%
Value US$12,080
3.9
Angela Cacace Officer Officer
Transaction date
Proposed sale
Price
11.89
Quantity 4,592
Value US$54,608
3.7
Andrew Saik Officer Officer
Transaction date
Proposed sale
Price
11.89
Quantity 5,134
Value US$61,053
3.8
Noah Berkowitz Officer Officer
Transaction date
Proposed sale
Price
11.89
Quantity 5,685
Value US$67,605
3.6
Randy Teel Officer Officer
Transaction date
Proposed sale
Price
11.89
Quantity 4,403
Value US$52,360
4.0
Loomis David K Chief Accounting Officer Officer
Transaction date
Planned sale
Price
9.89
Quantity 230 -0.7%
Value US$2,275
3.3
Morrison Briggs Non-Executive Director
Transaction date
Purchase
Price
7.57
Quantity 30,000 +65.2%
Value US$227,010
3.7
Saik Andrew Chief Financial Officer Officer
Transaction date
Sale
Price
7.61
Quantity 5,700 -3.4%
Value US$43,377
3.7
Andrew Saik Officer Officer
Transaction date
Proposed sale
Price
7.35
Quantity 5,927
Value US$43,593
3.9
Cacace Angela M Chief Scientific Officer Officer
Transaction date
Sale
Price
7.49
Quantity 2,583 -1.6%
Value US$19,347
3.8
Berkowitz Noah Chief Medical Officer Officer
Transaction date
Sale
Price
8.59
Quantity 8,658 -7.3%
Value US$74,372
3.8
Noah Berkowitz Officer Officer
Transaction date
Proposed sale
Price
8.59
Quantity 8,658
Value US$74,372
3.9
Cacace Angela M Chief Scientific Officer Officer
Transaction date
Sale
Price
16.55
Quantity 1,146 -1.2%
Value US$18,966
3.9
Cacace Angela M Chief Scientific Officer Officer
Transaction date
Sale
Price
16.75
Quantity 3,061 -3.0%
Value US$51,272
4.2
Houston John G President and CEO Executive Director
Transaction date
Sale
Price
16.55
Quantity 5,154 -0.4%
Value US$85,299
4.2
Houston John G President and CEO Executive Director
Transaction date
Sale
Price
16.75
Quantity 26,184 -2.2%
Value US$438,582
4.0
Loomis David K Chief Accounting Officer Officer
Transaction date
Sale
Price
16.75
Quantity 1,214 -6.0%
Value US$20,334
4.1
Taylor Ian President, R&D Officer
Transaction date
Sale
Price
16.55
Quantity 1,664 -1.0%
Value US$27,539
4.1
Taylor Ian President, R&D Officer
Transaction date
Sale
Price
16.75
Quantity 7,356 -4.4%
Value US$123,213
4.1
Ian Taylor Officer Officer
Transaction date
Proposed sale
Price
16.71
Quantity 9,020
Value US$150,730
4.2
John G Houston Officer; Director Executive Director
Transaction date
Proposed sale
Price
16.71
Quantity 31,338
Value US$523,801
3.9
Angela M Cacace Officer Officer
Transaction date
Proposed sale
Price
16.69
Quantity 4,207
Value US$70,230
4.0
Loomis David K Chief Accounting Officer Officer
Transaction date
Sale
Price
27.69
Quantity 231 -2.8%
Value US$6,396
3.8
Sean Cassidy retired CFO
Transaction date
Proposed sale
Price
33.00
Quantity 50,000
Value US$1,650,000
3.8
Sean Cassidy retired CFO
Transaction date
Proposed sale
Price
33.00
Quantity 35,000
Value US$1,155,000
3.8
Sean Cassidy retired CFO
Transaction date
Proposed sale
Price
33.40
Quantity 25,000
Value US$835,100
3.8
Sean Cassidy Officer Officer
Transaction date
Proposed sale
Price
32.00
Quantity 15,000
Value US$480,000
3.2
Peck Ronald Chief Medical Officer Officer
Transaction date
Sale
Price
47.05
Quantity 1,699 -2.5%
Value US$79,938
4.2
Houston John G President and CEO Executive Director
Transaction date
Sale
Price
47.05
Quantity 5,196 -0.5%
Value US$244,472
3.8
Cassidy Sean A Chief Financial Officer Officer
Transaction date
Sale
Price
47.05
Quantity 1,702 -0.9%
Value US$80,079
4.1
Taylor Ian Chief Scientific Officer Officer
Transaction date
Sale
Price
47.05
Quantity 1,701 -1.1%
Value US$80,032
4.0
Loomis David K Chief Accounting Officer Officer
Transaction date
Sale
Price
17.05
Quantity 229 -2.7%
Value US$3,904
3.2
Peck Ronald Chief Medical Officer Officer
Transaction date
Sale
Price
24.39
Quantity 1,324 -4.2%
Value US$32,289
4.2
Houston John G President and CEO Executive Director
Transaction date
Sale
Price
29.53
Quantity 5,878 -0.6%
Value US$173,577
3.8
Cassidy Sean A Chief Financial Officer Officer
Transaction date
Sale
Price
29.53
Quantity 1,745 -0.9%
Value US$51,530
4.1
Taylor Ian Chief Scientific Officer Officer
Transaction date
Sale
Price
29.53
Quantity 1,051 -1.0%
Value US$31,036
3.2
Peck Ronald Chief Medical Officer Officer
Transaction date
Sale
Price
68.99
Quantity 1,258 -13.4%
Value US$86,794
3.3
Morrison Briggs Non-Executive Director
Transaction date
Planned sale
Price
67.03
Quantity 10,754 -35.0%
Value US$720,888
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-09 2026-09-09 PrS Proposed sale
3.8
NOAH C BERKOWITZ

Former Officer

Officer
45,626
79.59
US$1,756,085 		45,626 79.59 US$1,756,085
2026-09-04 2026-09-04 PrS Proposed sale
3.8
NOAH C BERKOWITZ

Former Officer

Officer
58,488
338.50
US$78,796 		58,488 338.50 US$78,796
2026-08-04 2026-08-04 PrS Proposed sale
3.8
NOAH C BERKOWITZ

Officer

Officer
85,225
221.79
US$2,593,446 		85,225 221.79 US$2,593,446
2026-07-09 2026-07-09 PrS Proposed sale
3.8
NOAH C BERKOWITZ

Former Affiliate
24,000
8.40
US$201,528 		24,000 8.40 US$201,528
2026-06-24 2026-06-24 S Sale
3.7
Saik Andrew

Chief Financial Officer

Officer
5,696 -2.9%
8.16
US$46,474 		5,696 -2.9% 8.16 US$46,474
2026-06-23 2026-06-24 PrS Proposed sale
3.7
Andrew Saik

Officer

Officer
5,846
8.14
US$47,586 		5,846 8.14 US$47,586
2026-06-18 2026-06-17 S Sale
3.9
Cacace Angela M

Chief Scientific Officer

Officer
2,576 -1.4%
7.60
US$19,565 		2,576 -1.4% 7.60 US$19,565
2026-06-17 2026-06-17 PrS Proposed sale
3.9
Angela Cacace

Officer

Officer
2,642
7.42
US$19,604 		2,642 7.42 US$19,604
2026-05-22 2026-05-21 S Sale
3.6
Teel Randy

President and CEO

Executive Director
2,209 -0.8%
9.04
US$19,962 		2,209 -0.8% 9.04 US$19,962
2026-05-20 2026-05-21 PrS Proposed sale
3.6
Randy Teel

Officer; Director

Executive Director
2,197
9.10
US$19,993 		2,197 9.10 US$19,993
2026-05-13 2026-05-11 S Sale
4.0
Loomis David K

VP, Chief Accounting Officer

Officer
1,919 -4.6%
9.94
US$19,070 		1,919 -4.6% 9.94 US$19,070
2026-05-13 2026-05-11 S Sale
3.7
Saik Andrew

Chief Financial Officer

Officer
11,139 -5.5%
9.94
US$110,693 		11,139 -5.5% 9.94 US$110,693
2026-05-13 2026-05-11 S Sale
3.9
Cacace Angela M

Chief Scientific Officer

Officer
9,657 -5.0%
9.94
US$95,965 		9,657 -5.0% 9.94 US$95,965
2026-05-13 2026-05-11 S Sale
3.8
Berkowitz Noah

Chief Medical Officer

Officer
11,108 -5.5%
9.94
US$110,385 		11,108 -5.5% 9.94 US$110,385
2026-05-13 2026-05-11 S Sale
3.6
Teel Randy

President and CEO

Executive Director
9,657 -3.3%
9.94
US$95,965 		9,657 -3.3% 9.94 US$95,965
2026-05-08 2026-05-11 PrS Proposed sale
3.7
Andrew Saik

Officer

Officer
11,343
10.11
US$114,678 		11,343 10.11 US$114,678
2026-05-08 2026-05-11 PrS Proposed sale
3.9
Angela Cacace

Officer

Officer
9,834
10.11
US$99,422 		9,834 10.11 US$99,422
2026-05-08 2026-05-11 PrS Proposed sale
3.8
Noah Berkowitz

Officer

Officer
11,312
10.11
US$114,364 		11,312 10.11 US$114,364
2026-05-08 2026-05-11 PrS Proposed sale
3.6
Randy Teel

Officer; Director

Executive Director
9,834
10.11
US$99,422 		9,834 10.11 US$99,422
2026-03-19 2026-03-18 S Sale
3.8
Berkowitz Noah

Chief Medical Officer

Officer
6,435 -3.1%
11.10
US$71,431 		6,435 -3.1% 11.10 US$71,431
2026-03-17 2026-03-18 PrS Proposed sale
3.8
Noah Berkowitz

Officer

Officer
6,022
12.01
US$72,324 		6,022 12.01 US$72,324
2026-03-09 2026-03-06 B Purchase
3.3
Morrison Briggs
Non-Executive Director
20,000 +26.3%
13.40
US$268,070 		20,000 +26.3% 13.40 US$268,070
2026-03-02 2026-02-27 S Sale
4.2
Houston John G
Non-Executive Director
11,787 -1.0%
13.14
US$154,881 		11,787 -1.0% 13.14 US$154,881
2026-03-02 2026-02-27 S Sale
4.2
Houston John G
Non-Executive Director
18,822 -1.6%
13.24
US$249,203 		18,822 -1.6% 13.24 US$249,203
2026-03-02 2026-02-27 S Sale
4.2
Houston John G
Non-Executive Director
4,688 -0.4%
13.24
US$62,069 		4,688 -0.4% 13.24 US$62,069
2026-02-27 2026-02-27 PrS Proposed sale
4.2
John G. Houston

former President and CEO; Director

Non-Executive Director
35,297
13.21
US$466,184 		35,297 13.21 US$466,184
2026-02-25 2026-02-23 S Sale
4.0
Loomis David K

Chief Accounting Officer

Officer
1,108 -3.6%
12.16
US$13,473 		1,108 -3.6% 12.16 US$13,473
2026-02-25 2026-02-23 S Sale
3.9
Cacace Angela M

Chief Scientific Officer

Officer
2,571 -1.7%
12.16
US$31,263 		2,571 -1.7% 12.16 US$31,263
2026-02-25 2026-02-23 S Sale
3.9
Cacace Angela M

Chief Scientific Officer

Officer
1,038 -0.7%
12.16
US$12,622 		1,038 -0.7% 12.16 US$12,622
2026-02-25 2026-02-23 S Sale
3.6
Teel Randy

President and CEO

Executive Director
3,748 -2.4%
12.16
US$45,576 		3,748 -2.4% 12.16 US$45,576
2026-02-25 2026-02-23 S Sale
3.6
Teel Randy

President and CEO

Executive Director
1,038 -0.7%
12.16
US$12,622 		1,038 -0.7% 12.16 US$12,622
2026-02-23 2026-02-23 PrS Proposed sale
3.9
Angela Cacace

Officer

Officer
3,609
12.16
US$43,897 		3,609 12.16 US$43,897
2026-02-23 2026-02-23 PrS Proposed sale
3.6
Randy Teel

Officer; Director

Executive Director
4,786
12.16
US$58,213 		4,786 12.16 US$58,213
2026-02-18 2026-02-13 S Sale
3.6
Teel Randy

President and CEO

Executive Director
4,403 -2.8%
11.89
US$52,352 		4,403 -2.8% 11.89 US$52,352
2026-02-18 2026-02-13 S Sale
3.7
Saik Andrew

Chief Financial Officer

Officer
5,134 -3.1%
11.89
US$61,043 		5,134 -3.1% 11.89 US$61,043
2026-02-18 2026-02-13 PlS Planned sale
3.9
Cacace Angela M

Chief Scientific Officer

Officer
4,592 -2.9%
11.89
US$54,599 		4,592 -2.9% 11.89 US$54,599
2026-02-18 2026-02-13 S Sale
3.8
Berkowitz Noah

Chief Medical Officer

Officer
5,685 -3.4%
11.89
US$67,595 		5,685 -3.4% 11.89 US$67,595
2026-02-18 2026-02-13 PlS Planned sale
4.0
Loomis David K

Chief Accounting Officer

Officer
1,016 -3.2%
11.89
US$12,080 		1,016 -3.2% 11.89 US$12,080
2026-02-13 2026-02-13 PrS Proposed sale
3.9
Angela Cacace

Officer

Officer
4,592
11.89
US$54,608 		4,592 11.89 US$54,608
2026-02-13 2026-02-13 PrS Proposed sale
3.7
Andrew Saik

Officer

Officer
5,134
11.89
US$61,053 		5,134 11.89 US$61,053
2026-02-13 2026-02-13 PrS Proposed sale
3.8
Noah Berkowitz

Officer

Officer
5,685
11.89
US$67,605 		5,685 11.89 US$67,605
2026-02-13 2026-02-13 PrS Proposed sale
3.6
Randy Teel

Officer

Officer
4,403
11.89
US$52,360 		4,403 11.89 US$52,360
2025-11-07 2025-11-07 PlS Planned sale
4.0
Loomis David K

Chief Accounting Officer

Officer
230 -0.7%
9.89
US$2,275 		230 -0.7% 9.89 US$2,275
2025-09-24 2025-09-22 B Purchase
3.3
Morrison Briggs
Non-Executive Director
30,000 +65.2%
7.57
US$227,010 		30,000 +65.2% 7.57 US$227,010
2025-06-24 2025-06-24 S Sale
3.7
Saik Andrew

Chief Financial Officer

Officer
5,700 -3.4%
7.61
US$43,377 		5,700 -3.4% 7.61 US$43,377
2025-06-23 2025-06-24 PrS Proposed sale
3.7
Andrew Saik

Officer

Officer
5,927
7.35
US$43,593 		5,927 7.35 US$43,593
2025-06-18 2025-06-17 S Sale
3.9
Cacace Angela M

Chief Scientific Officer

Officer
2,583 -1.6%
7.49
US$19,347 		2,583 -1.6% 7.49 US$19,347
2025-03-19 2025-03-18 S Sale
3.8
Berkowitz Noah

Chief Medical Officer

Officer
8,658 -7.3%
8.59
US$74,372 		8,658 -7.3% 8.59 US$74,372
2025-03-18 2025-03-18 PrS Proposed sale
3.8
Noah Berkowitz

Officer

Officer
8,658
8.59
US$74,372 		8,658 8.59 US$74,372
2025-02-25 2025-02-24 S Sale
3.9
Cacace Angela M

Chief Scientific Officer

Officer
1,146 -1.2%
16.55
US$18,966 		1,146 -1.2% 16.55 US$18,966
2025-02-25 2025-02-24 S Sale
3.9
Cacace Angela M

Chief Scientific Officer

Officer
3,061 -3.0%
16.75
US$51,272 		3,061 -3.0% 16.75 US$51,272
2025-02-25 2025-02-24 S Sale
4.2
Houston John G

President and CEO

Executive Director
5,154 -0.4%
16.55
US$85,299 		5,154 -0.4% 16.55 US$85,299
2025-02-25 2025-02-24 S Sale
4.2
Houston John G

President and CEO

Executive Director
26,184 -2.2%
16.75
US$438,582 		26,184 -2.2% 16.75 US$438,582
2025-02-25 2025-02-24 S Sale
4.0
Loomis David K

Chief Accounting Officer

Officer
1,214 -6.0%
16.75
US$20,334 		1,214 -6.0% 16.75 US$20,334
2025-02-25 2025-02-24 S Sale
4.1
Taylor Ian

President, R&D

Officer
1,664 -1.0%
16.55
US$27,539 		1,664 -1.0% 16.55 US$27,539
2025-02-25 2025-02-24 S Sale
4.1
Taylor Ian

President, R&D

Officer
7,356 -4.4%
16.75
US$123,213 		7,356 -4.4% 16.75 US$123,213
2025-02-24 2025-02-24 PrS Proposed sale
4.1
Ian Taylor

Officer

Officer
9,020
16.71
US$150,730 		9,020 16.71 US$150,730
2025-02-24 2025-02-24 PrS Proposed sale
4.2
John G Houston

Officer; Director

Executive Director
31,338
16.71
US$523,801 		31,338 16.71 US$523,801
2025-02-24 2025-02-24 PrS Proposed sale
3.9
Angela M Cacace

Officer

Officer
4,207
16.69
US$70,230 		4,207 16.69 US$70,230
2024-11-12 2024-11-07 S Sale
4.0
Loomis David K

Chief Accounting Officer

Officer
231 -2.8%
27.69
US$6,396 		231 -2.8% 27.69 US$6,396
2024-05-20 2024-05-20 PrS Proposed sale
3.8
Sean Cassidy

retired CFO
50,000
33.00
US$1,650,000 		50,000 33.00 US$1,650,000
2024-05-16 2024-05-16 PrS Proposed sale
3.8
Sean Cassidy

retired CFO
35,000
33.00
US$1,155,000 		35,000 33.00 US$1,155,000
2024-05-15 2024-05-15 PrS Proposed sale
3.8
Sean Cassidy

retired CFO
25,000
33.40
US$835,100 		25,000 33.40 US$835,100
2024-05-13 2024-05-13 PrS Proposed sale
3.8
Sean Cassidy

Officer

Officer
15,000
32.00
US$480,000 		15,000 32.00 US$480,000
2024-02-27 2024-02-23 S Sale
3.2
Peck Ronald

Chief Medical Officer

Officer
1,699 -2.5%
47.05
US$79,938 		1,699 -2.5% 47.05 US$79,938
2024-02-27 2024-02-23 S Sale
4.2
Houston John G

President and CEO

Executive Director
5,196 -0.5%
47.05
US$244,472 		5,196 -0.5% 47.05 US$244,472
2024-02-27 2024-02-23 S Sale
3.8
Cassidy Sean A

Chief Financial Officer

Officer
1,702 -0.9%
47.05
US$80,079 		1,702 -0.9% 47.05 US$80,079
2024-02-27 2024-02-23 S Sale
4.1
Taylor Ian

Chief Scientific Officer

Officer
1,701 -1.1%
47.05
US$80,032 		1,701 -1.1% 47.05 US$80,032
2024-11-12 2023-11-08 S Sale
4.0
Loomis David K

Chief Accounting Officer

Officer
229 -2.7%
17.05
US$3,904 		229 -2.7% 17.05 US$3,904
2023-08-14 2023-08-11 S Sale
3.2
Peck Ronald

Chief Medical Officer

Officer
1,324 -4.2%
24.39
US$32,289 		1,324 -4.2% 24.39 US$32,289
2023-03-03 2023-03-01 S Sale
4.2
Houston John G

President and CEO

Executive Director
5,878 -0.6%
29.53
US$173,577 		5,878 -0.6% 29.53 US$173,577
2023-03-03 2023-03-01 S Sale
3.8
Cassidy Sean A

Chief Financial Officer

Officer
1,745 -0.9%
29.53
US$51,530 		1,745 -0.9% 29.53 US$51,530
2023-03-03 2023-03-01 S Sale
4.1
Taylor Ian

Chief Scientific Officer

Officer
1,051 -1.0%
29.53
US$31,036 		1,051 -1.0% 29.53 US$31,036
2022-08-16 2022-08-12 S Sale
3.2
Peck Ronald

Chief Medical Officer

Officer
1,258 -13.4%
68.99
US$86,794 		1,258 -13.4% 68.99 US$86,794
2022-04-18 2022-04-14 PlS Planned sale
3.3
Morrison Briggs
Non-Executive Director
10,754 -35.0%
67.03
US$720,888 		10,754 -35.0% 67.03 US$720,888
Explore more

More insider trading research around Arvinas Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America